b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="bmj" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2779854/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779854/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="The BMJ" /><meta name="citation_title" content="The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment" /><meta name="citation_authors" content="Richard D Smith, Marcus R Keogh-Brown, Tony Barnett, Joyce Tait" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="339" /><meta name="citation_doi" content="10.1136/bmj.b4571" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2779854/?report=abstract" /><meta name="citation_pmid" content="19926697" /><meta name="DC.Title" content="The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BMJ Publishing Group" /><meta name="DC.Contributor" content="Richard D Smith" /><meta name="DC.Contributor" content="Marcus R Keogh-Brown" /><meta name="DC.Contributor" content="Tony Barnett" /><meta name="DC.Contributor" content="Joyce Tait" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1136/bmj.b4571" /><meta name="DC.Language" content="en" /><meta property="og:title" content="The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment" /><meta property="og:type" content="article" /><meta property="og:description" content="Objectives To estimate the potential economic impact of pandemic influenza, associated behavioural responses, school closures, and vaccination on the United Kingdom.Design A computable general equilibrium model of the UK economy was specified for various ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779854/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-bmj.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2779854/epub/" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A3260E9A383910000000006590659.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/3/">BMJ</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/266528/">v.339; 2009</a></li><li class="accid">PMC2779854</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-bmj.gif" alt="Logo of bmj" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,75" alt="This Article" title="This Article" href="//dx.doi.org/10.1136/bmj.b4571" ref="reftype=publisher&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="0,0,500,75" alt="The BMJ" title="The BMJ" href="http://bmj.co/pubmed14" ref="reftype=publisher&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMJ</span>. 2009; 339: b4571. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Nov 19. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1136%2Fbmj.b4571" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1136/bmj.b4571</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2779854</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19926697">19926697</a></div></div></div></div><h1 class="content-title">The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Smith%20RD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697" class="affpopup" co-rid="_co_idm139896257467168" co-class="co-affbox">Richard D Smith</a>, <span class="fm-role">professor of health system economics</span>,<sup></sup><sup>1</sup> <a href="/pubmed/?term=Keogh-Brown%20MR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697" class="affpopup" co-rid="_co_idm139896249434576" co-class="co-affbox">Marcus R Keogh-Brown</a>, <span class="fm-role">research fellow in economic modelling</span>,<sup>1</sup> <a href="/pubmed/?term=Barnett%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697" class="affpopup" co-rid="_co_idm139896257463408" co-class="co-affbox">Tony Barnett</a>, <span class="fm-role">professorial research fellow and honorary professor</span>,<sup>1,</sup><sup>2</sup> and  <a href="/pubmed/?term=Tait%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697" class="affpopup" co-rid="_co_idm139896257460432" co-class="co-affbox">Joyce Tait</a>, <span class="fm-role">professor and scientific adviser</span><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139896257467168"><h3 class="no_margin">Richard D Smith</h3><p><sup>1</sup>Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT</p><div>Find articles by <a href="/pubmed/?term=Smith%20RD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697">Richard D Smith</a></div></div><div id="_co_idm139896249434576"><h3 class="no_margin">Marcus R Keogh-Brown</h3><p><sup>1</sup>Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT</p><div>Find articles by <a href="/pubmed/?term=Keogh-Brown%20MR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697">Marcus R Keogh-Brown</a></div></div><div id="_co_idm139896257463408"><h3 class="no_margin">Tony Barnett</h3><p><sup>1</sup>Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT</p><p><sup>2</sup>London School of Economics and Political Science, London WC2A 2AE</p><div>Find articles by <a href="/pubmed/?term=Barnett%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697">Tony Barnett</a></div></div><div id="_co_idm139896257460432"><h3 class="no_margin">Joyce Tait</h3><p><sup>3</sup>ESRC Innogen Centre, University of Edinburgh, Edinburgh EH1 1LZ</p><div>Find articles by <a href="/pubmed/?term=Tait%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19926697">Joyce Tait</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139896260841744_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139896260841744_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139896260841744_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139896260841744_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1"><sup>1</sup>Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT</div><div class="fm-affl" lang="en" id="aff2"><sup>2</sup>London School of Economics and Political Science, London WC2A 2AE</div><div class="fm-affl" lang="en" id="aff3"><sup>3</sup>ESRC Innogen Centre, University of Edinburgh, Edinburgh EH1 1LZ</div><div id="idm139896248617936">Correspondence to: R D Smith <a href="mailto:dev@null" data-email="ku.ca.mthsl@htims.drahcir" class="oemail">ku.ca.mthsl@htims.drahcir</a></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139896260841744_an" style="display:none"><div class="fm-pubdate half_rhythm">Accepted 2009 Nov 2.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139896260841744_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: <a href="http://creativecommons.org/licenses/by-nc/2.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc/2.0/</a> and <a href="http://creativecommons.org/licenses/by-nc/2.0/legalcode" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc/2.0/legalcode</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2779854/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139896259903152" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139896259903152title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first"><strong>Objectives</strong> To estimate the potential economic impact of pandemic influenza, associated behavioural responses, school closures, and vaccination on the United Kingdom.</p><p id="__p2"><strong>Design</strong> A computable general equilibrium model of the UK economy was specified for various combinations of mortality and morbidity from pandemic influenza, vaccine efficacy, school closures, and prophylactic absenteeism using published data.</p><p id="__p3"><strong>Setting</strong> The 2004 UK economy (the most up to date available with suitable economic data).</p><p id="__p4"><strong>Main outcome measures</strong> The economic impact of various scenarios with different pandemic severity, vaccination, school closure, and prophylactic absenteeism specified in terms of gross domestic product, output from different economic sectors, and equivalent variation.</p><p id="__p5"><strong>Results</strong> The costs related to illness alone ranged between 0.5% and 1.0% of gross domestic product (&#x000a3;8.4bn to &#x000a3;16.8bn) for low fatality scenarios, 3.3% and 4.3% (&#x000a3;55.5bn to &#x000a3;72.3bn) for high fatality scenarios, and larger still for an extreme pandemic. School closure increases the economic impact, particularly for mild pandemics. If widespread behavioural change takes place and there is large scale prophylactic absence from work, the economic impact would be notably increased with few health benefits. Vaccination with a pre-pandemic vaccine could save 0.13% to 2.3% of gross domestic product (&#x000a3;2.2bn to &#x000a3;38.6bn); a single dose of a matched vaccine could save 0.3% to 4.3% (&#x000a3;5.0bn to &#x000a3;72.3bn); and two doses of a matched vaccine could limit the overall economic impact to about 1% of gross domestic product for all disease scenarios.</p><p id="__p6" class="p p-last"><strong>Conclusion</strong> Balancing school closure against &#x0201c;business as usual&#x0201d; and obtaining sufficient stocks of effective vaccine are more important factors in determining the economic impact of an influenza pandemic than is the disease itself. Prophylactic absence from work in response to fear of infection can add considerably to the economic impact.</p></div></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">Introduction</h2><p id="__p7" class="p p-first">In the past century there were three major influenza pandemics (1918, 1957, and 1968-9).<sup><a href="#ref1" rid="ref1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691389">1</a></sup> This century has seen an outbreak of severe acute respiratory syndrome (2003), H1N1 subtype of the influenza A virus (2009), and sporadic outbreaks of H5N1 influenza subtype.<sup><a href="#ref2" rid="ref2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691396">2</a></sup> In addition to the direct health impacts of a serious outbreak, we should be concerned about the economic impact; especially at a time of global recession.<sup><a href="#ref3" rid="ref3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173029">3</a></sup> Preparedness planning for a pandemic must therefore balance two key policy strands&#x02014;maintaining &#x0201c;business as usual&#x0201d; to minimise the economic impact of a pandemic, and encouraging &#x0201c;social distancing&#x0201d; to minimise the health related impact of a pandemic<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup>&#x02014;as well using resources such as antivirals and vaccinations.</p><p id="__p8" class="p p-last">This paper considers the tension inherent in these two policy strands. It provides evidence of the economy-wide impact of each approach, as well as the impact that vaccine development may have in reconciling the two objectives of minimising both the health and economic effects of a pandemic. A key consideration in this analysis is the role of public perception and confidence, expressed by &#x0201c;prophylactic absenteeism,&#x0201d; where healthy people avoid social contact, including going to work. This response is likely to emerge at higher case fatality rates and to be moderated by the availability of effective vaccines (the current strain of H1N1 influenza seems to be highly infectious but not very deadly, and this may explain its limited economic impact to date).</p></div><div id="__sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec2title">Methods</h2><p id="__p9" class="p p-first">The analysis is based on a computable general equilibrium model of the UK<sup><a href="#ref5" rid="ref5" class=" bibr popnode">5</a></sup> over one year. The economy is specified in terms of several agents, including households, producers, and government, and based on data (in the form of a social accounting matrix, which represents income and expenditure in the economy by sector) for 2004 taken from the Global Trade Analysis Database<sup><a href="#ref6" rid="ref6" class=" bibr popnode">6</a></sup> and national statistics.<sup><a href="#ref7" rid="ref7" class=" bibr popnode">7</a></sup>\n<sup><a href="#ref8" rid="ref8" class=" bibr popnode">8</a></sup> Computable general equilibrium modelling is described in further detail by Dervis et al.<sup><a href="#ref9" rid="ref9" class=" bibr popnode">9</a></sup></p><p id="__p10" class="p">The economic impact of influenza in our model is assumed to occur through the labour supply, since illness and death cause both a reduction in the availability of labour and in its quality. Mitigation actions can also affect the labour supply by (<em>a</em>) reducing labour when people are kept away from the workplace to avoid infection or (<em>b</em>) by increasing labour supply compared with non-mitigated pandemic scenarios by reducing the number of infections and deaths<sup><a href="#ref10" rid="ref10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173033">10</a></sup> and reducing the extent to which people feel the need to engage in prophylactic absenteeism.</p><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3 id="__sec3title">Glossary of terms</h3><ul class="simple" style="list-style-type:none"><!--\nlist-behavior=simple\nprefix-word=\nmark-type=none\nmax-label-size=0\n--><li><p id="__p11"><strong>Computable general equilibrium model&#x02014;</strong>A mathematical model of the whole economy that includes the cost minimising and profit maximising behaviour of producers, the consumption and saving behaviour of households and government, taxation mechanisms, and the use of labour, capital, and other factors in order to produce goods for investment or consumption. The model produces a benchmark solution which is then compared with alternative solutions incorporating policy change or other events simulated by the model. Counterfactual solutions can be compared with the benchmark solution to estimate the economic impact of the simulated policy or event.</p></li><li><p id="__p12"><strong>Social accounting matrix&#x02014;</strong>A matrix that represents the balanced income and expenditure flows of a regional, national, or global economy aggregated to make them a manageable size for use in a computable general equilibrium model. (The matrix rows represent income to the economy and the columns represent expenditure.)</p></li><li><p id="__p13"><strong>Global trade model&#x02014;</strong>A computable general equilibrium model of the global economy.</p></li><li><p id="__p14"><strong>Prophylactic absenteeism&#x02014;</strong>Absence from work of a healthy individual in order to avoid infection.</p></li><li><p id="__p15"><strong>Clinical attack rate&#x02014;</strong>The percentage of individuals in a population who become infected.</p></li><li><p id="__p16"><strong>Case fatality rate&#x02014;</strong>The percentage of infected individuals who die.</p></li><li><p id="__p17"><strong>Mortality rate&#x02014;</strong>Percentage of individuals in a total population who die (clinical attack rate &#x000d7; case fatality rate).</p></li><li><p id="__p18"><strong>Reactive school closure&#x02014;</strong>Government closure of a school to reduce infection when a (government defined) proportion of children or staff is experiencing illness.</p></li><li><p id="__p19"><strong>School closure associated with prophylactic absenteeism&#x02014;</strong>Closure of schools caused by the amount of prophylactic absence by staff.</p></li><li><p id="__p20"><strong>Transition point&#x02014;</strong>The point at which the severity of the pandemic provokes sufficient fear to invoke a sudden increase in prophylactic absenteeism within the population.</p></li></ul></div></div><div id="__sec4" class="sec"><h3 id="__sec4title">Pandemic impact</h3><p id="__p21" class="p p-first">Pandemic planning documents<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup>\n<sup><a href="#ref11" rid="ref11" class=" bibr popnode">11</a></sup>\n<sup><a href="#ref12" rid="ref12" class=" bibr popnode">12</a></sup> anticipate clinical attack rates between 25% and 35%, with a maximum of 50%. We therefore use these three values in our disease scenarios. Based on previous pandemics, predicted case fatality rates for the UK range from 0.2% to 2.5%,<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup>\n<sup><a href="#ref12" rid="ref12" class=" bibr popnode">12</a></sup>\n<sup><a href="#ref13" rid="ref13" class=" bibr popnode">13</a></sup> and the summary estimate for European pandemic preparedness plans is 0.37%.<sup><a href="#ref11" rid="ref11" class=" bibr popnode">11</a></sup> We used 0.4% as our base disease scenario and 2.5% for our severe scenario, with an extreme scenario of 10% based on severe acute respiratory syndrome (SARS).<sup><a href="#ref13" rid="ref13" class=" bibr popnode">13</a></sup>\n<sup><a href="#ref14" rid="ref14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173028">14</a></sup> We therefore have nine possible combinations of clinical attack rate and case fatality rate.</p><p id="__p22" class="p p-last">While deaths permanently remove labour from the workforce, absenteeism represents temporary removal. Illness absence will result in subsequent immunity to the virus, whereas those undertaking prophylactic absenteeism will still be vulnerable to infection. The Commission of the European Communities suggests that the duration of pandemic influenza illness is five to eight working days,<sup><a href="#ref11" rid="ref11" class=" bibr popnode">11</a></sup> and absence for seasonal flu is approximately five days.<sup><a href="#ref15" rid="ref15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691398">15</a></sup> We therefore assume five days of illness for our mild scenario, seven days for severe, and 22 days for the extreme scenario, which is based on hospitalisation rates for SARS.<sup><a href="#ref16" rid="ref16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173034">16</a></sup>\n<sup><a href="#ref17" rid="ref17" class=" bibr popnode">17</a></sup> All absences are estimated as a percentage of time lost from a working year of 220 days.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Pandemic mitigation: vaccination</h3><p id="__p23" class="p p-first">Although the US recently announced that it expects to go from vaccine trial to mass vaccination within two months,<sup><a href="#ref18" rid="ref18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691390">18</a></sup> and the UK has signed agreements (with GSK and Baxter) to purchase 132 million doses of pandemic-specific vaccine,<sup><a href="#ref19" rid="ref19" class=" bibr popnode">19</a></sup> specific vaccines are unlikely to be available for the first wave of infection.<sup><a href="#ref20" rid="ref20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691410">20</a></sup> During this stage, pre-pandemic vaccines, based on existing virus strains, will be the only option for protection, giving approximately 20% efficacy and, when combined with other clinical countermeasures, reducing the pandemic&#x02019;s impact to that of seasonal influenza.<sup><a href="#ref21" rid="ref21" class=" bibr popnode">21</a></sup> Once matched vaccines become available they are likely to have 70-80% efficacy, probably requiring two doses at an interval of three weeks. Vaccine shelf life is currently about one year.<sup><a href="#ref22" rid="ref22" class=" bibr popnode">22</a></sup></p><p id="__p24" class="p p-last">We assumed two vaccination strategies&#x02014;a pre-pandemic vaccine with 20% efficacy and a matched vaccine with 40% efficacy (single dose) and 80% efficacy (double dose).<sup><a href="#ref23" rid="ref23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691406">23</a></sup> For all vaccines we assumed sufficient stocks for 60% coverage. Vaccination would have two potential impacts on a pandemic, reducing the number of infected individuals and moderating the extent of prophylactic absenteeism because people feel protected from infection.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">Pandemic mitigation: school closure</h3><p id="__p25" class="p p-first">School closures are believed to reduce the impact of the pandemic, since infection rates among children are high,<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup> and this is mentioned in many pandemic planning documents.<sup><a href="#ref12" rid="ref12" class=" bibr popnode">12</a></sup>\n<sup><a href="#ref24" rid="ref24" class=" bibr popnode">24</a></sup>\n<sup><a href="#ref25" rid="ref25" class=" bibr popnode">25</a></sup>\n<sup><a href="#ref26" rid="ref26" class=" bibr popnode">26</a></sup> Although we witnessed closure at the early stages of the H1N1 influenza pandemic, it has been suggested that closure later, when the epidemic is better established, will be more effective in delaying spread, but also inevitable if large sectors of the population adopt prophylactic absenteeism in the face of increasing reports of deaths.<sup><a href="#ref27" rid="ref27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691400">27</a></sup> It is therefore important to distinguish between school closure as a reactive policy to a pandemic and school closure associated with prophylactic absenteeism.</p><p id="__p26">Ferguson et al<sup><a href="#ref10" rid="ref10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173030">10</a></sup> suggest that reactive school closure will result in closure for 95% of the 15 weeks of the pandemic, regardless of how often they reopen (duration of school closure associated with prophylactic absenteeism cannot, of course, be known). Previous studies<sup><a href="#ref28" rid="ref28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691411">28</a></sup>\n<sup><a href="#ref29" rid="ref29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691388">29</a></sup> have assumed school closure at the four week peak of the pandemic, allowing for some variation around the two or three week disease peak cited in the Department of Health&#x02019;s pandemic plan.<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup> Any school closure policy will result in disruption for working parents and, based on peak pandemic duration and Ferguson&#x02019;s estimates, we present scenarios with four weeks and 14.25 weeks of school closure. We also consider the mitigation impact of school closure, which is estimated as 2% for a 34% clinical attack rate in the Ferguson paper and up to a maximum of between 13% and 17% in the paper by Cauchemez et al,<sup><a href="#ref30" rid="ref30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173032">30</a></sup> which we approximate as 15%.</p><p id="__p27" class="p p-last">The UK Labour Force Survey (2005) suggests that 25&#x02009;245&#x02009;000 individuals aged 16-64 are in paid employment, of whom 3&#x02009;900&#x02009;000 are women who have dependent children in the household. That is, 15.5% of the workforce comprises women who are probably responsible for dependent children.<sup><a href="#ref31" rid="ref31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691386">31</a></sup> A small proportion of working men is also reported to be responsible for dependent children,<sup><a href="#ref32" rid="ref32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691402">32</a></sup> bringing potential absenteeism estimates through school closure to 16.1%. However, we made some attempt to correct this estimate to account for informal care by grandparents, working from home, etc. In addition, we assumed that those 54% of working parents who maintain working hours during school closure because of informal care<sup><a href="#ref32" rid="ref32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691385">32</a></sup> will lose working hours equivalent to one person&#x02019;s illness duration when their informal caregiver is ill.</p></div><div id="__sec7" class="sec sec-last"><h3 id="__sec7title">Pandemic mitigation: prophylactic absenteeism</h3><p id="__p28" class="p p-first">Previous studies<sup><a href="#ref28" rid="ref28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691394">28</a></sup>\n<sup><a href="#ref29" rid="ref29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691405">29</a></sup>\n<sup><a href="#ref33" rid="ref33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173036">33</a></sup> have shown that a main driver of economic impact is behavioural change. Behavioural change can include changes in consumption patterns and prophylactic absence from work to avoid infection. Prophylactic absence from work is likely to be governed by personal choice related to fear and therefore is unlikely to be proportionate. There will be a transition point when the number of individuals who decide to take relatively drastic social distancing action to avoid infection increases rapidly over a short space of time.</p><p id="__p29">We suggest that the transition point in public behaviour related to an influenza pandemic is likely to be heavily influenced by the case fatality rate but to be reasonably independent of the clinical attack rate since illness, by itself, causes limited fear if a full recovery is anticipated. The public response to the current H1N1 pandemic supports this.</p><p id="__p30">The level of the case fatality rate at which such a transition point will occur is likely to be related to the density of deaths in &#x0201c;effective social networks&#x0201d;&#x02014;that is, the prospect of death becomes rapidly personalised with the death of a member of one&#x02019;s network of relatives, friends, colleagues, and acquaintances. To our knowledge, no study has been conducted to determine the impact of prophylactic absenteeism on modelling predictions related to disease and economic impacts. Accurate estimation of this transition point for pandemic influenza would require extensive survey work, and it would be useful to undertake such research in future so as to build up a body of knowledge relevant to the kind of modelling reported here. In its absence we have selected the conservative value of about 300 people as the effective social network, to include close contacts such as family and friends (10-12 people), acquaintances, and work colleagues.<sup><a href="#ref34" rid="ref34" class=" bibr popnode">34</a></sup>\n<sup><a href="#ref35" rid="ref35" class=" bibr popnode">35</a></sup>\n<sup><a href="#ref36" rid="ref36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691401">36</a></sup>\n<sup><a href="#ref37" rid="ref37" class=" bibr popnode">37</a></sup>\n<sup><a href="#ref38" rid="ref38" class=" bibr popnode">38</a></sup> On this basis almost everybody in the population will know someone who has died once the mortality rate reaches one death per 300 people, triggering prophylactic absenteeism.</p><p id="__p31">Simple arithmetic suggests that there are 200&#x02009;000 discrete effective social networks in the UK (60&#x02009;000&#x02009;000/300). However, many of these will overlap, and so the real figure for the number of discrete social networks involved in communication of news of a death, taking into account Facebook, texting, and other networking tools, is likely to be smaller. In the absence of research on this topic, a case fatality rate in the range 2.5-5% seems to be a valid assumption for the expected transition point.</p><p id="__p32">Not all individuals will avoid work during a pandemic, but a survey conducted after the SARS outbreak<sup><a href="#ref31" rid="ref31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691391">31</a></sup> indicated that about 34% of the working population in Europe would be willing to take prophylactic absence from work in the event of an infectious disease outbreak. Although survey responses do not always reflect true behavioural responses, it is reasonable to assume that the 34% of respondents who reported themselves as willing, in theory, to avoid work for a serious pandemic, would do so at the transition point presented above.</p><p id="__p33">It is difficult to predict the duration of such absenteeism, as high levels of fear might cause prolonged periods of absence by some. However, it might reasonably be assumed that in most cases, absentees would be forced to take annual leave (as longer term sick leave usually requires a doctor&#x02019;s authorisation). On this assumption, absenteeism is likely to last up to four weeks, and, since the peak of the pandemic is likely to last two or three weeks<sup><a href="#ref4" rid="ref4" class=" bibr popnode">4</a></sup> and the transition point is unlikely to be reached before the peak, this is presumed to be a reasonable upper limit.</p><p id="__p34" class="p">Table 1<a href="/pmc/articles/PMC2779854/table/tbl1/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl1" rid-ob="ob-tbl1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">1</span></span><span></span></a> provides a summary of the assumed parameter estimates used in our disease scenarios together with the sources of these estimates.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p35">&#x02002;Parameter assumptions and their sources used to estimate effects of pandemic influenza and possible responses to it</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139896220123680" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom">Parameter</th><th colspan="1" rowspan="1" align="center" valign="bottom">Estimates</th><th colspan="1" rowspan="1" align="center" valign="bottom">Evidence</th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Clinical attack rate</td><td colspan="1" rowspan="1" align="left" valign="top">25% (mild); 35% (moderate); 50% (high)</td><td colspan="1" rowspan="1" align="left" valign="top">Department of Health (2007)<sup>4</sup>; Commission of the European Communities (2005)<sup>11</sup>; Health Protection Agency (2006)<sup>12</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Case fatality rate</td><td colspan="1" rowspan="1" align="left" valign="top">0.4% (low); 2.5% (high); 10% (extreme)</td><td colspan="1" rowspan="1" align="left" valign="top">Department of Health (2008)<sup>13</sup>; Stadler et al (2003)<sup>14</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Duration of illness (working days)</td><td colspan="1" rowspan="1" align="left" valign="top">5 (low); 7 (high); 22 (extreme)</td><td colspan="1" rowspan="1" align="left" valign="top">Commission of the European Communities (2005)<sup>11</sup>; Postma et al (2005)<sup>15</sup>; Peiris et al (2003)<sup>16</sup>; McLean et al (2005)<sup>17</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">No of working days per year</td><td colspan="1" rowspan="1" align="left" valign="top">220</td><td colspan="1" rowspan="1" align="left" valign="top">Assumes 104 days are weekends, 8 days are bank holidays, and 33 days of annual leave or other absence</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Pre-pandemic vaccine efficacy</td><td colspan="1" rowspan="1" align="left" valign="top">20%</td><td colspan="1" rowspan="1" align="left" valign="top">Department of Health (2007)<sup>21</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Matched vaccine efficacy</td><td colspan="1" rowspan="1" align="left" valign="top">40% (single dose); 80% (double dose)</td><td colspan="1" rowspan="1" align="left" valign="top">Leroux-Roels et al (2008)<sup>23</sup></td></tr><tr><td colspan="1" rowspan="2" align="left" valign="top">School closure duration</td><td colspan="1" rowspan="1" align="left" valign="top">4 weeks</td><td colspan="1" rowspan="1" align="left" valign="top">Based on duration of peak of pandemic, Department of Health (2007)<sup>4</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">14.25 weeks (95% of 15 week duration)</td><td colspan="1" rowspan="1" align="left" valign="top">15 weeks based on duration of pandemic, Department of Health (2007)<sup>4</sup>; 95% of duration based on Ferguson et al (2006)<sup>10</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Percentage of parents needing to take time off work if schools were closed</td><td colspan="1" rowspan="1" align="left" valign="top">16.1%</td><td colspan="1" rowspan="1" align="left" valign="top">Sadique et al (2008)<sup>33</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Percentage of parents with access to informal care</td><td colspan="1" rowspan="1" align="left" valign="top">54%</td><td colspan="1" rowspan="1" align="left" valign="top">Sadique et al (2008)<sup>33</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Density of effective social networks</td><td colspan="1" rowspan="1" align="left" valign="top">300 people</td><td colspan="1" rowspan="1" align="left" valign="top">Cheng et al (2004)<sup>34</sup>; Chombart de Lauwe et al (1953)<sup>35</sup>; Ko et al (2006)<sup>36</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Percentage of population willing to take prophylactic absence at the transition point</td><td colspan="1" rowspan="1" align="left" valign="top">34%</td><td colspan="1" rowspan="1" align="left" valign="top">Sadique et al (2007)<sup>31</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Duration of prophylactic absence</td><td colspan="1" rowspan="1" align="left" valign="top">4 weeks</td><td colspan="1" rowspan="1" align="left" valign="top">Based on limitations of annual leave and duration of peak pandemic, Department of Health (2007)<sup>4</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Transition point when prophylactic absence becomes widespread</td><td colspan="1" rowspan="1" align="left" valign="top">When &#x02265;1 death occurs in every social network*</td><td colspan="1" rowspan="1" align="left" valign="top">See density of effective social networks</td></tr><tr><td colspan="1" rowspan="2" align="left" valign="top">Mitigation impact of school closures</td><td colspan="1" rowspan="1" align="left" valign="top">Reduction in clinical attack rate equivalent to 2% in a pandemic with 34% clinical attack rate</td><td colspan="1" rowspan="1" align="left" valign="top">Ferguson et al (2006)<sup>10</sup></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">15% reduction in CAR</td><td colspan="1" rowspan="1" align="left" valign="top">Cauchemez et al (2009)<sup>30</sup></td></tr></tbody></table></div><div id="largeobj_idm139896220123680" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2779854/table/tbl1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p36">*When mortality rate (clinical attack rate &#x000d7; case fatality rate) is &#x02265;1/300.</p></div></div></div></div><div id="__sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec8title">Results</h2><div id="__sec9" class="sec sec-first"><h3 id="__sec9title">Model of economic impact of pandemic influenza</h3><p id="__p37" class="p p-first">The accuracy of these results is subject to the scenarios we have outlined, the model specification, and the economic data from 2004 underlying the model. Figure 1<a href="/pmc/articles/PMC2779854/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">1</span></span><span></span></a> shows the impact of various disease and mitigation scenarios on gross domestic product: disease only (with no mitigation), disease with four weeks of school closure, disease with pre-pandemic vaccine, disease with matched vaccine (single dose), and disease with matched vaccine (double dose). Each scenario is plotted for low, medium, and high clinical attack rate (25%, 35%, and 50%) and low, high, and extreme case fatality rates (0.4%, 2.5%, and 10%), although both rates are adjusted to allow for mitigation effects in the mitigation scenarios.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC2779854/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139896256761904" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4787477_smir708164.f1_default.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is smir708164.f1_default.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2779854/bin/smir708164.f1_default.jpg" /></a></div><div id="largeobj_idm139896256761904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2779854/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><!--caption a7--><div class="caption"><p id="__p38"><strong>Fig 1</strong> Effect of pandemic influenza on UK gross domestic product (GDP) according to various disease and mitigation scenarios (all vaccination strategies assumed to have 60% coverage)</p></div></div></div><div id="__sec10" class="sec"><p></p><h4 id="__sec10title" class="inline">Low case fatality rate </h4><p id="__p39" class="p p-first-last">The first three histogram bars show the impact of a low case fatality rate, in which variations in clinical attack rate have little impact (loss of 0.51-1.02% of gross domestic product). However, the impact of four weeks of school closure is large, doubling or even tripling the impact of the disease alone. The results also show that in a low fatality pandemic a pre-pandemic vaccine might result in savings of 0.13-0.26% of gross domestic product, and a matched vaccine could result in savings of 0.26-0.51% for a single dose and 0.49-0.96% for a double dose. The transition point of prophylactic absenteeism is not reached in any of the scenarios with a low case fatality rate.</p></div><div id="__sec11" class="sec"><p></p><h4 id="__sec11title" class="inline">High case fatality rate </h4><p id="__p40" class="p p-first">With a high case fatality rate, however, the transition point is reached (mortality rate becomes similar to that of the 1918 pandemic), so that individual change in behaviour to avoid infection yields large impacts of 3.3%, 3.7%, and 4.3% of gross domestic product for the low, medium, and high infection rates, respectively&#x02014;emphasising that the mortality rate can, in such circumstances, be a more important determinant of economic impact than the infection rate. </p><p id="__p41" class="p p-last">The introduction of school closures in high fatality scenarios has less impact than in low fatality scenarios, with an additional impact of 0.75-0.8% of gross domestic product. A pre-pandemic vaccine would be insufficient to avoid the transition point in a high fatality pandemic and so would reduce the impact on gross domestic product by only 0.33-0.64%. A matched vaccine, even if only single dose, would have sufficient effect to avoid the transition point and could therefore result in savings of 2.6-3.2% of gross domestic product (roughly equivalent to half of the impact of the financial crisis over the past year (<a href="http://www.statistics.gov.uk/instantfigures.asp" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.statistics.gov.uk/instantfigures.asp</a>)). Two doses of a matched vaccine are likely to reduce the impact further, yielding savings of 3-4%.</p></div><div id="__sec12" class="sec sec-last"><p></p><h4 id="__sec12title" class="inline">Extreme case fatality rate </h4><p id="__p42" class="p p-first-last">The extreme fatality scenarios predictably yield the largest impacts. Our assumptions dictate that for such a serious pandemic the transition point would be passed, and the low, medium, and high infection scenarios yield reductions in gross domestic product of 6.0%, 7.4%, and 9.6%, respectively. School closure increases this impact by 0.63-0.77%, which is smaller than for the less severe scenarios as the mitigation impact of school closure reduces the severity of the disease. Pre-pandemic vaccine has some effect on reducing the impact of the school closure scenarios by 1.2-2.3%, and a single dose of matched vaccine yields slightly larger savings of 2.2-4.3%. The matched vaccine with two doses is the only mitigation strategy that avoids the transition to prophylactic absenteeism in the extreme fatality scenarios, reducing the overall impact of the pandemic to 1.1-1.2% of gross domestic product (much less than the impact of the current financial crisis).</p></div></div><div id="__sec13" class="sec"><h3 id="__sec13title">Alternative scenarios</h3><p id="__p43" class="p p-first">Alternatives to these scenarios have also been modelled but are not reported in detail here. In brief, schools closing for about 95% of the 15 weeks of the pandemic&#x02019;s duration and assuming a mitigation equivalent to 2% if the clinical attack rate was 34%, as outlined by Ferguson et al,<sup><a href="#ref10" rid="ref10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173031">10</a></sup> produces a 2.5% further reduction in gross domestic product compared with our four week closure scenarios; it reduces the infection rates, but the dominance of the case fatality rate in determining the transition point is such that the degree of prophylactic absenteeism remains the same. </p><p id="__p44">Similarly, informal care by grandparents and friends, reducing the level of prophylactic absenteeism from 16.1% to 8.7%,<sup><a href="#ref32" rid="ref32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_519691397">32</a></sup> reduces the loss to gross domestic product by 0.56-0.58% in the four week school closure scenarios and by 1.8-2.0% in the longer closure scenario. Assuming the higher mitigation rate of 15% suggested by Cauchemez et al,<sup><a href="#ref30" rid="ref30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173027">30</a></sup> which would apply to longer school closure scenarios, the severity of the economic impact of school closures is reduced in proportion to the severity of the pandemic. This reduction is quite small&#x02014;up to 0.25% of gross domestic product for non-extreme scenarios and up to 0.9% of gross domestic product in the most extreme and unmitigated scenario&#x02014;so overall reductions in gross domestic product are still between 1% and 2% larger than with the four week school closure scenarios. School closure&#x02019;s failure to mitigate the impact of the disease despite the assumption of its efficacy is due to the large amount of absenteeism induced by school closures, which, in our model, is not affected by the clinical attack rate.</p><p id="__p45" class="p p-last">Additional scenarios relating to the swine flu pandemic and alternative vaccine efficacy assumptions are included in an online appendix.</p></div><div id="__sec14" class="sec"><h3 id="__sec14title">Impact of pandemic on different economic sectors</h3><p id="__p46" class="p p-first">Figure 2<a href="/pmc/articles/PMC2779854/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">2</span></span><span></span></a> shows the impact on different sectors of the economy for the 35% clinical attack rate and 0.4% case fatality rate scenario. The pattern is similar across scenarios. The lowest impacts are seen in the extraction sector (mining, quarrying, forestry and fishing) followed by crops, utilities, and health and non-health services. The largest impacts are in the meat and livestock, processed foods, textiles/paper/plastics, manufacturing, and transport and communications sectors.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC2779854/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139896260844256" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4787477_smir708164.f2_default.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is smir708164.f2_default.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2779854/bin/smir708164.f2_default.jpg" /></a></div><div id="largeobj_idm139896260844256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2779854/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><!--caption a7--><div class="caption"><p id="__p47"><strong>Fig 2</strong> Impact of pandemic influenza on different economic sectors of UK gross domestic product (GDP)</p></div></div></div></div><div id="__sec15" class="sec sec-last"><h3 id="__sec15title">Equivalent variation</h3><p id="__p48" class="p p-first">Computable general equilibrium modelling also produces the welfare measure of equivalent variation, which represents the amount of money that, if an economic change does not happen, leaves the population just as well off as if the change had occurred. This may be thought of as the amount of money that the population might be willing to pay to avert the pandemic. For the purposes of this paper, the welfare measure is quoted as a percentage of gross domestic product, with the results presented in table 2<a href="/pmc/articles/PMC2779854/table/tbl2/" target="table" class="fig-table-link figpopup" rid-figpopup="tbl2" rid-ob="ob-tbl2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">2.</span></span><span></span></a>. In order to avoid the economic impact of the pandemic, the cost that the population might be willing to pay ranges from 0.7% (&#x000a3;11.8bn) for the mildest disease-only scenario to 14% (&#x000a3;235bn) for the most extreme. School closure increases these values to 5.1% (&#x000a3;85.8bn) in the mildest scenario to 17.9% (&#x000a3;301.1bn) for the most severe scenario.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="tbl2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p49">&#x02002;Equivalent variation as percentage of gross domestic product (GDP) and &#x000a3;bn for different influenza pandemic scenarios</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139896250226672" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th colspan="2" rowspan="1" align="center" valign="bottom">Pandemic scenario</th><th colspan="1" rowspan="2" align="left" valign="bottom"></th><th colspan="2" rowspan="1" align="center" valign="bottom">Disease only</th><th colspan="1" rowspan="2" align="center" valign="bottom"></th><th colspan="2" rowspan="1" align="center" valign="bottom">4 week school closure</th></tr><tr><th colspan="1" rowspan="1" align="left" valign="bottom">Case fatality rate</th><th colspan="1" rowspan="1" align="left" valign="bottom">Clinical attack rate</th><th colspan="1" rowspan="1" align="center" valign="bottom">% of GDP</th><th colspan="1" rowspan="1" align="center" valign="bottom">&#x000a3;bn</th><th colspan="1" rowspan="1" align="center" valign="bottom">% of GDP</th><th colspan="1" rowspan="1" align="center" valign="bottom">&#x000a3;bn</th></tr></thead><tbody><tr><td colspan="1" rowspan="3" align="left" valign="middle">Low</td><td colspan="1" rowspan="1" align="left" valign="top">Low</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;0.7</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;11.8</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;5.1</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;85.8</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Medium</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;1</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;16.8</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;5.4</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;90.8</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">High</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;1.5</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;25.2</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;5.8</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;97.6</td></tr><tr><td colspan="1" rowspan="3" align="left" valign="middle">High</td><td colspan="1" rowspan="1" align="left" valign="top">Low</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;4.8</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;80.7</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;8.8</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;148.0</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Medium</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;5.4</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;90.8</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;9.4</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;158.1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">High</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;6.3</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;106.0</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;10.3</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;173.2</td></tr><tr><td colspan="1" rowspan="3" align="left" valign="middle">Extreme</td><td colspan="1" rowspan="1" align="left" valign="top">Low</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;8.7</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;146.3</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;12.7</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;213.6</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Medium</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;10.8</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;181.7</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;14.8</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;248.9</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">High</td><td colspan="1" rowspan="1" align="left" valign="top"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;14</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;235.5</td><td colspan="1" rowspan="1" align="center" valign="bottom"></td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;17.9</td><td colspan="1" rowspan="1" align="center" valign="bottom">&#x02212;301.1</td></tr></tbody></table></div><div id="largeobj_idm139896250226672" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2779854/table/tbl2/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="__sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec16title">Discussion</h2><p id="__p50" class="p p-first">Our results show that, depending on the disease severity, pandemic influenza alone could reduce gross domestic product by 0.5-4.3%. Extending fatality rates beyond those observed in previous pandemics to a SARS-like case fatality rate of 10% yields an impact of 5.9-9.6% of gross domestic product (&#x000a3;99.2bn to &#x000a3;161.5bn). School closure, and its related absenteeism, causes a notable increase in economic loss, and caution might therefore be advised in pursuing this policy when the case fatality rate is low.</p><p id="__p51">A pre-pandemic vaccine with moderate efficacy and 60% coverage could result in large relative savings for any low or high fatality pandemic of &#x000a3;2.2bn-&#x000a3;10.8bn, or &#x000a3;20.2bn-&#x000a3;39.0bn for extreme scenarios. A matched vaccine, even if only available in sufficient time for a single dose to be administered to 60% of the population, would result in substantially higher savings, in both low and high fatality scenarios, and a double dose of a matched vaccine could keep the reduce the loss in gross domestic product to below 3%, even with the most extreme pandemic and long school closures&#x02014;which is little more than half the impact of the current recession, although recovery from a severe flu event would probably be much more rapid. Estimates suggest that the planned H1N1 flu vaccination will cost about &#x000a3;6 per person (<a href="http://www.bloomberg.com/apps/news?pid=20601124&#x00026;sid=auYQiQYJ.73I" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.bloomberg.com/apps/news?pid=20601124&#x00026;sid=auYQiQYJ.73I</a>), yielding a total cost of about &#x000a3;792m, compared with savings that start from &#x000a3;2.2bn for the mildest pandemic. Our results suggest that, even in a mild pandemic, a vaccination costing &#x000a3;16.60 per person would be beneficial in terms of its health impact without imposing a burden on the economy.</p><p id="__p52" class="p">Our results also consider the possibility that there is a transition point in case fatality rate, above which many individuals might change their usual behaviour and avoid work in an attempt to avoid infection. Evidence suggests that 50% prophylactic absence, which is larger than our assumed absence rates, is likely to reduce a 34% clinical attack rate by only 1% (case fatality rate is unchanged as this is dependent on the disease).<sup><a href="#ref10" rid="ref10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848173035">10</a></sup> Since these absence rates could cost the economy billions of pounds, prophylactic absence should be discouraged except in exceptional circumstances.</p><div id="__sec17" class="sec"><h3 id="__sec17title">Limitations and strengths of study</h3><p id="__p53" class="p p-first">This work does not take into account consumption effects from avoidance of public places, entertainment events, and changes in shopping patterns, although further work is under way to establish an evidence base from which these effects can be modelled. Impacts on trade, imports, and exports have not been examined here as it is difficult to assess these impacts accurately with a single-country model. A study with a global trade model is ongoing and will supplement the findings presented here. </p><p id="__p54" class="p p-last">The strength of our findings depends on the underlying assumptions which, though based on published evidence where possible, are subject to the bias of surveys, the unpredictability of the disease and its resultant impact on policies and behavioural change. We included estimates of school closure and prophylactic absence, but their true values in the middle of a pandemic could vary widely. However, this paper extends previous work<sup><a href="#ref24" rid="ref24" class=" bibr popnode">24</a></sup> by using the best available estimates to approximate the impact of social networks on behavioural change, considering various lengths of school closure, their feedback effects on the pandemic, and the impact of informal care both in mitigating absenteeism due to school closure and in causing absenteeism by parents when informal carers are unwell, as well as considering the impact of various vaccination strategies on disease and behaviour change.</p></div><div id="__sec18" class="sec sec-last"><h3 id="__sec18title">Conclusion</h3><p id="__p55" class="p p-first">Pandemic influenza itself, if it occurs within the bounds of severity outlined in pandemic plans, will not yield unprecedented economic impacts: even a high fatality pandemic with high levels of infection would reduce gross domestic product by less than 4.5%. However, two factors will compound the disease&#x02019;s impact. Firstly, a pandemic in the near future would impose additional strain on an economy that is already stretched by recession, exaggerating the effect of recession and slowing economic recovery. Secondly, although the direct economic impact of disease is relatively small, school closures and prophylactic absenteeism, whether imposed by government or the result of fear of infection in the population, could greatly increase the economic impact.</p><p id="__p56">In the event of a mild pandemic, long periods of school closures will not be necessary and could greatly multiply the economic impact of the disease and should therefore be minimised. In more serious pandemics, the relative economic impact of school closures decreases and the gains from school closure in mitigating the pandemic increase, so a policy of school closure should take into account the severity of the disease. However, such a policy should be limited in its duration&#x02014;sufficient to maximise the lowering of peak disease levels and maintain a functioning health service, but allowing schools to open at other times. In an extreme pandemic, the relative incremental cost of school closure is small and should not influence policies that would minimise deaths.</p><p id="__p57" class="p">Our &#x0201c;transition point&#x0201d; estimates provide an example of how fear induced behavioural change could greatly increase the economic impact of a pandemic while providing questionable health gains. We suggest that the overall mortality rate is the driver of this behavioural change, and vaccinations, whether pre-pandemic or matched vaccine, could be extremely important in preventing mortality rates from reaching the &#x0201c;transition point.&#x0201d; The cost of vaccinations is likely to be less than the economic savings gained from vaccination, even in the mildest of pandemics, and in the event of a high or extreme fatality pandemic a matched vaccine might be the only method to avoid the unprecedented economic effects of behavioural change.</p><div class="boxed-text-box whole_rhythm hide-overflow"><div class="sec"><h3 id="__sec19title">What is already known on this topic</h3><ul class="simple" style="list-style-type:none"><!--\nlist-behavior=simple\nprefix-word=\nmark-type=none\nmax-label-size=0\n--><li><p id="__p58">Fear induced behavioural changes or government sanctioned absences from work or school in response to a flu pandemic could have a substantial economic impact, and these losses may not be balanced by large health benefits</p></li></ul></div><div class="sec"><h3 id="__sec20title">What this paper adds</h3><ul class="simple" style="list-style-type:none"><!--\nlist-behavior=simple\nprefix-word=\nmark-type=none\nmax-label-size=0\n--><li><p id="__p59">Vaccines play a major role in mitigating the economic impact of a pandemic regardless of the characteristics of the disease</p></li><li><p id="__p60">If increased fear caused by deaths within an individual&#x02019;s social network provoke prophylactic absence from work, large economic loss could result</p></li></ul></div></div></div></div><div id="idm139896292683200" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139896292683200title">Notes</h2><p class="fn-group"><p class="fn sec" id="idm139896292682944"><p id="__p61" class="p p-first-last">Contributors: RDS conceived the idea of a computable general equilibrium application for influenza, advised on the modelling and scenarios, and contributed to the drafting of the paper. MRK-B was responsible for the modelling, the underlying dataset, construction of modelling scenarios and shocks, and drafted the paper. TB and JT conceived the idea of the transition point based on social networking theory, advised on the scenarios and vaccination strategies, and contributed to the drafting of the paper. MRK-B is guarantor for the study.</p></p><p class="fn sec" id="idm139896292681520"><p id="__p62" class="p p-first-last">Funding: No specific funding for this study<strong>.</strong></p></p><p class="fn sec" id="idm139896292680400"> <p id="__p63" class="p p-first-last">Competing interests: None declared.</p></p><p class="fn sec" id="idm139896292679536"><p id="__p64" class="p p-first-last">Ethical approval: Not required for this study.</p></p><p class="fn sec" id="idm139896292678912"><p id="__p65" class="p p-first-last">Data sharing: Model output data are available on request from MR Keogh-Brown <a href="mailto:dev@null" data-email="ku.ca.mthsl@nworb-hgoek.sucram" class="oemail">ku.ca.mthsl@nworb-hgoek.sucram</a></p></p></p></div><div id="idm139896249164192" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139896249164192title">Notes</h2><p id="__p66">Cite this as: <em>BMJ</em> 2009;339:b4571</p></div><div id="idm139896292678032" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139896292678032title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="ref1">1. <span class="mixed-citation">Macfarlane JT, Lim WS. Bird flu and pandemic flu. <span class="ref-journal">BMJ</span> 2005;<span class="ref-vol">331</span>:975-6. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1273436/">PMC free article</a>]</span> [<a href="/pubmed/16246859" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;volume=331&amp;publication_year=2005&amp;pages=975&amp;pmid=16246859&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref2">2. <span class="mixed-citation">Coker R. Swine flu. <span class="ref-journal">BMJ</span> 2009;<span class="ref-vol">338</span>:b1791. [<a href="/pubmed/19406879" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;volume=338&amp;publication_year=2009&amp;pages=b1791&amp;pmid=19406879&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref3">3. <span class="mixed-citation">Keogh-Brown MR, Smith RD. The economic impact of SARS: how does the reality match the predictions? <span class="ref-journal">Health Policy</span> 2008;<span class="ref-vol">88</span>:110-20. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7114672/">PMC free article</a>]</span> [<a href="/pubmed/18436332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Health+Policy&amp;volume=88&amp;publication_year=2008&amp;pages=110&amp;pmid=18436332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref4">4. <span class="mixed-citation">Department of Health. Pandemic influenza: a national framework for responding to an influenza pandemic. DH, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="ref5">5. <span class="mixed-citation">L&#x000f6;fgren H, Harris RL, Robinson S. <span class="ref-journal">A standard computable general equilibrium (CGE) model in GAMS</span>. International Food Policy Research Institute (IFPRI), 2001.</span></div><div class="ref-cit-blk half_rhythm" id="ref6">6. <span class="mixed-citation">Narayanan B, Walmsley TL. <span class="ref-journal">Global trade, assistance, and production: the GTAP 7 data base</span>. Center for Global Trade Analysis, Purdue University, 2008.</span></div><div class="ref-cit-blk half_rhythm" id="ref7">7. <span class="mixed-citation">Fofona I, Lemelin A, Cockburn J. Balancing a social accounting matrix: theory and application. Centre Interuniversitaire sur le Risque les Politiques Economiques et L&#x02019;Emploi (CIRPEE), 2005.</span></div><div class="ref-cit-blk half_rhythm" id="ref8">8. <span class="mixed-citation">Arndt C, Robinson S, Tarp F. Parameter estimation for a computable general equilibrium model: a maximum entropy approach. Perdue University, IFPRI, University of Copenhagen, 1999. (Discussion paper No 40.)</span></div><div class="ref-cit-blk half_rhythm" id="ref9">9. <span class="mixed-citation">Dervis K, de Malo J, Robinson S. General equilibrium models for development policy. Cambridge University Press, 1982.</span></div><div class="ref-cit-blk half_rhythm" id="ref10">10. <span class="mixed-citation">Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. <span class="ref-journal">Nature</span> 2006;<span class="ref-vol">442</span>:448-52. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7095311/">PMC free article</a>]</span> [<a href="/pubmed/16642006" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;volume=442&amp;publication_year=2006&amp;pages=448&amp;pmid=16642006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref11">11. <span class="mixed-citation">Commission of the European Communities. Communication from the commission to the council, the European parliament, the European economic and social committee and the committee of the regions on pandemic influenza preparedness and response planning in the European community. EC, 2005.</span></div><div class="ref-cit-blk half_rhythm" id="ref12">12. <span class="mixed-citation">Health Protection Agency. Pandemic influenza contingency plan. HPA, 2006.</span></div><div class="ref-cit-blk half_rhythm" id="ref13">13. <span class="mixed-citation">Department of Health. Scientific Pandemic Influenza Advisory Committee (SPI): subgroup on modelling, modelling summary. DH, 2008.</span></div><div class="ref-cit-blk half_rhythm" id="ref14">14. <span class="mixed-citation">Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk H-D, et al. SARS&#x02014;beginning to understand a new virus. <span class="ref-journal">Nat Rev Micro</span> 2003;<span class="ref-vol">1</span>:209-18. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7097337/">PMC free article</a>]</span> [<a href="/pubmed/15035025" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Micro&amp;volume=1&amp;publication_year=2003&amp;pages=209&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref15">15. <span class="mixed-citation">Postma MJ, Jansema P, Sheijbeler HWKFH, van Genugten MLL. Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults. <span class="ref-journal">Vaccine</span> 2005;<span class="ref-vol">23</span>:5365-71. [<a href="/pubmed/16029916" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;volume=23&amp;publication_year=2005&amp;pages=5365&amp;pmid=16029916&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref16">16. <span class="mixed-citation">Peiris JSM, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. <span class="ref-journal">Lancet</span> 2003;<span class="ref-vol">361</span>:1767-72. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112410/">PMC free article</a>]</span> [<a href="/pubmed/12781535" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;volume=361&amp;publication_year=2003&amp;pages=1767&amp;pmid=12781535&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref17">17. <span class="mixed-citation">McLean A, May R, Pattison J, Weiss R. SARS: a case study in emerging infections. Oxford University Press, 2005.</span></div><div class="ref-cit-blk half_rhythm" id="ref18">18. <span class="mixed-citation">Butler D. US puts flu vaccines on trial. <span class="ref-journal">Nature News</span> 2009;<span class="ref-vol">460</span>:562 (<a href="http://www.nature.com/news/2009/090728/full/460562a.htms" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">www.nature.com/news/2009/090728/full/460562a.htms</a>). [<a href="/pubmed/19641566" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+News&amp;volume=460&amp;publication_year=2009&amp;pages=562&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref19">19. <span class="mixed-citation">Department of Health. Agreements secured for pre-pandemic vaccine in the UK. DH, 2009 (<a href="http://www.dh.gov.uk/en/Publichealth/Flu/Swineflu/DH_099248" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">www.dh.gov.uk/en/Publichealth/Flu/Swineflu/DH_099248</a>).</span></div><div class="ref-cit-blk half_rhythm" id="ref20">20. <span class="mixed-citation">Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing: challenges and solutions. <span class="ref-journal">Nat Biotechnol</span> 2006;<span class="ref-vol">24</span>:1377-83. [<a href="/pubmed/17093488" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;volume=24&amp;publication_year=2006&amp;pages=1377&amp;pmid=17093488&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref21">21. <span class="mixed-citation">Department of Health. Pre-pandemic and pandemic influenza vaccines: scientific evidence base. DH, 2007 (<a href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_077276" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_077276</a>).</span></div><div class="ref-cit-blk half_rhythm" id="ref22">22. <span class="mixed-citation">European Centre for Disease Prevention and Control. Technical report: expert advisory groups on human H5N1 vaccines, scientific questions.ECDC, 2007.</span></div><div class="ref-cit-blk half_rhythm" id="ref23">23. <span class="mixed-citation">Leroux-Roels I, Bernhard R, Gerard P, Drame M, Hanon E, Leroux-Roels G. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. <span class="ref-journal">PLoS One</span> 2008;<span class="ref-vol">3</span>:e1665. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2253495/">PMC free article</a>]</span> [<a href="/pubmed/18301743" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;volume=3&amp;publication_year=2008&amp;pages=e1665&amp;pmid=18301743&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref24">24. <span class="mixed-citation">Department of Health. UK Health Departments&#x02019; Influenza pandemic contingency plan. DH, 2005.</span></div><div class="ref-cit-blk half_rhythm" id="ref25">25. <span class="mixed-citation">US Department of Health and Human Services. HHS pandemic influenza plan. HHS, 2005.</span></div><div class="ref-cit-blk half_rhythm" id="ref26">26. <span class="mixed-citation">Public Health Agency of Canada. The Canadian pandemic influenza plan for the health sector. PHA, 2006.</span></div><div class="ref-cit-blk half_rhythm" id="ref27">27. <span class="mixed-citation">Cauchemez S, Valleron A-J, Boelle P-Y, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from Sentinel data. <span class="ref-journal">Nature</span> 2008;<span class="ref-vol">452</span>:750-4. [<a href="/pubmed/18401408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;volume=452&amp;publication_year=2008&amp;pages=750&amp;pmid=18401408&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref28">28. <span class="mixed-citation">Keogh-Brown MR, Smith RD, Edmunds W, Beutels P. The macroeconomic impact of pandemic influenza: estimates from models of the UK, France, Belgium and the Netherlands. <span class="ref-journal">Eur J Health Econ </span>(forthcoming). [<a href="/pubmed/19997956" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="ref29">29. <span class="mixed-citation">Keogh-Brown MR, Wren-Lewis S, Edmunds WJ, Beutels P, Smith RD. The possible macroeconomic impact on the UK of an influenza pandemic. <span class="ref-journal">Health Econ</span> [forthcoming]. [<a href="/pubmed/19816886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="ref30">30. <span class="mixed-citation">Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, et al. Closure of schools during an influenza pandemic. <span class="ref-journal">Lancet Infect Dis</span> 2009;<span class="ref-vol">9</span>:473-81. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7106429/">PMC free article</a>]</span> [<a href="/pubmed/19628172" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;volume=9&amp;publication_year=2009&amp;pages=473&amp;pmid=19628172&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref31">31. <span class="mixed-citation">Sadique MZ, Edmunds WJ, Smith RD, Meerding WJ, de Zwart O, Brug J, et al. Precautionary behavior in response to perceived threat of pandemic influenza. <span class="ref-journal">Emerg Infect Dis</span> 2007;<span class="ref-vol">13</span>:1307-13. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2857294/">PMC free article</a>]</span> [<a href="/pubmed/18252100" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;volume=13&amp;publication_year=2007&amp;pages=1307&amp;pmid=18252100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref32">32. <span class="mixed-citation">Sadique MZ, Adams E, Edmunds W. Estimating the costs of school closure for mitigating an influenza pandemic. <span class="ref-journal">BMC Public Health</span> 2008;<span class="ref-vol">8</span>:135. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2377259/">PMC free article</a>]</span> [<a href="/pubmed/18435855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Public+Health&amp;volume=8&amp;publication_year=2008&amp;pages=135&amp;pmid=18435855&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref33">33. <span class="mixed-citation">Keogh-Brown MR, Smith RD. The economic impact of SARS: how does the reality match the predictions. <span class="ref-journal">Health Policy</span> 2008;<span class="ref-vol">88</span>:110-20. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7114672/">PMC free article</a>]</span> [<a href="/pubmed/18436332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Health+Policy&amp;volume=88&amp;publication_year=2008&amp;pages=110&amp;pmid=18436332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref34">34. <span class="mixed-citation">Cheng C, Tang C. The psychology behind the masks: psychological responses to the severe acute respiratory syndrome outbreak in different regions. <span class="ref-journal">Asian Journal of Social Psychology </span> 2004;<span class="ref-vol">7</span>:3-7. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Asian+Journal+of+Social+Psychology+&amp;volume=7&amp;publication_year=2004&amp;pages=3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref35">35. <span class="mixed-citation">Chombart de Lauwe PH, Antoine S, Bertin JLC, CouvreurCJG. Paris et l&#x02019;agglomeration parisienne. <span class="ref-journal">Revue Fran&#x000e7;aise de Science Politique</span> 1953;<span class="ref-vol">3</span>(3):630-3. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Revue+Fran&#x000e7;aise+de+Science+Politique&amp;volume=3&amp;publication_year=1953&amp;pages=630&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref36">36. <span class="mixed-citation">Ko C, Yen C, Yen J, Yang M. Psychosocial impact among the public of the severe acute respiratory syndrome epidemic in Taiwan. <span class="ref-journal">Psychiatry Clin Neurosci</span> 2006;<span class="ref-vol">60</span>:297-403. [<a href="/pubmed/16884438" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychiatry+Clin+Neurosci&amp;volume=60&amp;publication_year=2006&amp;pages=297&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2779854&amp;issue-id=266528&amp;journal-id=3&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref37">37. <span class="mixed-citation">Wang H, Wellman B. Social connectivity in America: changes in adult friendship network size from 2002 to 2007. <span class="ref-journal">American Behavioral Scientist</span> [forthcoming].</span></div><div class="ref-cit-blk half_rhythm" id="ref38">38. <span class="mixed-citation">Spencer L, Pahl R. <span class="ref-journal">Rethinking friendship: hidden solidarities today</span>. Princeton University Press, 2006.</span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">The BMJ</span> are provided here courtesy of <strong>BMJ Publishing Group</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2779854/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2779854/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2779854/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC2779854" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2779854%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2779854%2F&amp;text=The%20economy-wide%20impact%20of%20pandemic%20influenza%20on%20the%20UK%3A%20a%20computable%20general%20equilibrium%20modelling%20experiment"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2779854%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19926697" data-aiid="4787477" data-aid="2779854" data-iid="266528" data-domainid="3" data-domain="bmj" data-accid="PMC2779854" data-md5="78f2d89fd6adaa7de05e73020a894de2"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:27:15-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A3260E9A383910000000006590659&amp;ncbi_session=8A1A3260E9A49631_1625SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2779854%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=bmj&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2779854/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A3260E9A49631_1625SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'